These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29748188)

  • 1. Factors Influencing the Decision to Proceed to Firmware Upgrades to Implanted Pacemakers for Cybersecurity Risk Mitigation.
    Saxon LA; Varma N; Epstein LM; Ganz LI; Epstein AE
    Circulation; 2018 Sep; 138(12):1274-1276. PubMed ID: 29748188
    [No Abstract]   [Full Text] [Related]  

  • 2. Pacemaker Cybersecurity: Local Experience With a Firmware Upgrade.
    Baranchuk A; Alexander B; Campbell D; Haseeb S; Redfearn D; Simpson C; Glover B
    Circulation; 2018 Sep; 138(12):1272-1273. PubMed ID: 29748189
    [No Abstract]   [Full Text] [Related]  

  • 3. CIED Cybersecurity Risks in an Increasingly Connected World.
    Paulsen JE; Hazelett MB; Schwartz SB
    Circulation; 2018 Sep; 138(12):1181-1183. PubMed ID: 30354433
    [No Abstract]   [Full Text] [Related]  

  • 4. Rates of Adoption and Outcomes After Firmware Updates for Food and Drug Administration Cybersecurity Safety Advisories.
    Saxon LA; Varma N; Epstein LM; Ganz LI; Epstein AE
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008364. PubMed ID: 32631098
    [No Abstract]   [Full Text] [Related]  

  • 5. Pacemaker Recall Highlights Security Concerns for Implantable Devices.
    Kuehn BM
    Circulation; 2018 Oct; 138(15):1597-1598. PubMed ID: 30354523
    [No Abstract]   [Full Text] [Related]  

  • 6. Are implanted electronic devices hackable?
    Alexander B; Haseeb S; Baranchuk A
    Trends Cardiovasc Med; 2019 Nov; 29(8):476-480. PubMed ID: 30482482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MY APPROACH to cybersecurity for cardiac implantable electronic devices.
    Baranchuk A; Alexander B; Haseeb S
    Trends Cardiovasc Med; 2019 Feb; 29(2):129-130. PubMed ID: 30396783
    [No Abstract]   [Full Text] [Related]  

  • 8. Permanent pacemakers and implantable defibrillators: considerations for intensivists.
    McPherson CA; Manthous C
    Am J Respir Crit Care Med; 2004 Nov; 170(9):933-40. PubMed ID: 15297272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.
    Maisel WH; Sweeney MO; Stevenson WG; Ellison KE; Epstein LM
    JAMA; 2001 Aug; 286(7):793-9. PubMed ID: 11497532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of pacemaker implantation in patients with transvenous (nonthoracotomy) implantable cardioverter defibrillators.
    Clemo HF; Ellenbogen KA; Belz MK; Wood MA; Stambler BS
    Pacing Clin Electrophysiol; 1994 Dec; 17(12 Pt 1):2285-91. PubMed ID: 7885936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: use caution when applying magnets to pacemakers or defibrillators for surgery.
    Schulman PM; Rozner MA
    Anesth Analg; 2013 Aug; 117(2):422-7. PubMed ID: 23757477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cybersecurity: The need for data and patient safety with cardiac implantable electronic devices.
    Das S; Siroky GP; Lee S; Mehta D; Suri R
    Heart Rhythm; 2021 Mar; 18(3):473-481. PubMed ID: 33059076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).
    Tjong FVY; Knops RE; Neuzil P; Petru J; Sediva L; Wilde AAM; Sperzel J; Reddy VY
    Circulation; 2018 Feb; 137(6):633-635. PubMed ID: 29431664
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantable Cardioverter-Defibrillator-Cybersecurity.
    Alexander B; Neira V; Campbell D; Crystal E; Simpson C; Enriquez A; Chacko S; Abdollah H; Redfearn D; Baranchuk A
    Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e008261. PubMed ID: 32078370
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stored electrograms in pacemakers and ICDs from Medtronic].
    Kloppe A; Kloppe C; Lemke B; Zarse M
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):26-40. PubMed ID: 20224933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of nerve conduction studies in patients with implanted cardiac devices.
    Schoeck AP; Mellion ML; Gilchrist JM; Christian FV
    Muscle Nerve; 2007 Apr; 35(4):521-4. PubMed ID: 17094099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary.
    Bigger JT; Kleiger RE
    Am J Cardiol; 2006 Nov; 98(9):1291-3. PubMed ID: 17056349
    [No Abstract]   [Full Text] [Related]  

  • 20. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
    Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
    Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.